Home Newsfeeds Revelation Biosciences Q2 EPS $(0.12)

Revelation Biosciences Q2 EPS $(0.12)

Revelation Biosciences (NASDAQ:REVB) reported quarterly losses of $(0.12) per share.

byMichael Horton

August 15, 2022

1 minute read

Revelation Biosciences (NASDAQ:REVB) reported quarterly losses of $(0.12) per share.

Apple’s Next-Gen AirTag Launch Said To Be Delayed Because There’s Simply A Lot Of Unsold Original Ones

By Ananya Gairola

January 7, 10:06 PM

As per the report, AirTag 2 is set to feature an upgraded wireless chip, in line with the latest components seen in iPhones and Apple Watches.

AAPL

SpaceX Halts Launch Of Intuitive Machines’ Robotic Moon Lander Due To Technical Glitch

By Benzinga Neuro

February 14, 3:52 AM

The much-anticipated launch of a private U.S. moon lander has been postponed due to a technical issue. The mission, which is being closely watched as part of the U.S.'s Artemis moon program, has been rescheduled for the following day.

LUNR

SVB Leerink Maintains Outperform on UnitedHealth Group, Raises Price Target to $625

By Benzinga Newsdesk

July 18, 10:23 AM

SVB Leerink analyst Whit Mayo maintains UnitedHealth Group (NYSE:UNH) with a Outperform and raises the price target from $600 to $625.

UNH

Canopy Growth, Tilray Pull Back After Enjoying Surge Following Biden’s Pardon: What’s Up With These Cannabis Stocks?

By Melanie Schaffer

October 7, 11:38 AM

Canopy Growth Corp. (NASDAQ: CGC) and Tilray Brands Inc. (NASDAQ: TLRY) were plunging over 13% and 11%, respectively, at one point Friday after skyrocketing on Thursday.

CGC

Revelation Biosciences Q2 EPS $(0.12)

Related Posts

Apple’s Next-Gen AirTag Launch Said To Be Delayed Because There’s Simply A Lot Of Unsold Original Ones

SpaceX Halts Launch Of Intuitive Machines’ Robotic Moon Lander Due To Technical Glitch

SVB Leerink Maintains Outperform on UnitedHealth Group, Raises Price Target to $625

Canopy Growth, Tilray Pull Back After Enjoying Surge Following Biden’s Pardon: What’s Up With These Cannabis Stocks?